JP2024511611A5 - - Google Patents
Info
- Publication number
- JP2024511611A5 JP2024511611A5 JP2023558350A JP2023558350A JP2024511611A5 JP 2024511611 A5 JP2024511611 A5 JP 2024511611A5 JP 2023558350 A JP2023558350 A JP 2023558350A JP 2023558350 A JP2023558350 A JP 2023558350A JP 2024511611 A5 JP2024511611 A5 JP 2024511611A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- carbonyl
- decane
- azaspiro
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2104097.7A GB202104097D0 (en) | 2021-03-24 | 2021-03-24 | Pharmaceutical compounds |
| GB2104097.7 | 2021-03-24 | ||
| PCT/EP2022/057820 WO2022200523A1 (en) | 2021-03-24 | 2022-03-24 | Pharmaceuticals compounds as inhibitors of ubiquitin specific protease 19 (usp19) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511611A JP2024511611A (ja) | 2024-03-14 |
| JP2024511611A5 true JP2024511611A5 (https=) | 2025-03-26 |
Family
ID=75689814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558350A Pending JP2024511611A (ja) | 2021-03-24 | 2022-03-24 | ユビキチン特異的プロテアーゼ１９阻害剤としての医薬化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240327382A1 (https=) |
| EP (1) | EP4313295A1 (https=) |
| JP (1) | JP2024511611A (https=) |
| KR (1) | KR20230160901A (https=) |
| CN (1) | CN117157285A (https=) |
| AU (1) | AU2022244178A1 (https=) |
| BR (1) | BR112023019323A2 (https=) |
| CA (1) | CA3212236A1 (https=) |
| GB (1) | GB202104097D0 (https=) |
| IL (1) | IL307163A (https=) |
| MX (1) | MX2023011012A (https=) |
| WO (1) | WO2022200523A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115656383A (zh) * | 2022-11-11 | 2023-01-31 | 武汉海特生物创新医药研究有限公司 | 一种alpha-苯基哌啶-2-乙酰胺对映异构体的检测方法 |
| GB202311227D0 (en) | 2023-07-21 | 2023-09-06 | Almac Discovery Ltd | Pharmaceutical compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335701B1 (en) * | 2003-12-15 | 2012-07-11 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US9938300B2 (en) * | 2015-02-05 | 2018-04-10 | Forma Therapeutics, Inc. | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors |
| US9840491B2 (en) * | 2015-02-05 | 2017-12-12 | Forma Therapeutics, Inc. | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors |
| EP3253765A1 (en) * | 2015-02-05 | 2017-12-13 | Forma Therapeutics, Inc. | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors |
| GB201612938D0 (en) | 2016-07-26 | 2016-09-07 | Almac Discovery Ltd | Pharmaceutical compounds |
| JP7402792B2 (ja) * | 2017-09-26 | 2023-12-21 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 多発性骨髄腫を治療するための新規なｕｓｐ７阻害剤 |
| GB201801562D0 (en) * | 2018-01-31 | 2018-03-14 | Almac Diagnostics Ltd | Pharmaceutical compounds |
| MX2021006542A (es) * | 2018-12-06 | 2021-07-07 | Almac Discovery Ltd | Inhibidores de la usp19 para usarse en terapia. |
| CN113365696A (zh) * | 2018-12-06 | 2021-09-07 | 阿尔麦克探索有限公司 | 药物化合物和其作为泛素特异性蛋白酶19(usp19)抑制剂的用途 |
| EP3965749A4 (en) * | 2019-05-06 | 2023-06-21 | Valo Health, Inc. | ESCAPEMENT OF USP19 |
-
2021
- 2021-03-24 GB GBGB2104097.7A patent/GB202104097D0/en not_active Ceased
-
2022
- 2022-03-24 KR KR1020237036567A patent/KR20230160901A/ko active Pending
- 2022-03-24 CN CN202280025417.6A patent/CN117157285A/zh active Pending
- 2022-03-24 AU AU2022244178A patent/AU2022244178A1/en active Pending
- 2022-03-24 IL IL307163A patent/IL307163A/en unknown
- 2022-03-24 MX MX2023011012A patent/MX2023011012A/es unknown
- 2022-03-24 WO PCT/EP2022/057820 patent/WO2022200523A1/en not_active Ceased
- 2022-03-24 BR BR112023019323A patent/BR112023019323A2/pt unknown
- 2022-03-24 EP EP22718158.3A patent/EP4313295A1/en active Pending
- 2022-03-24 JP JP2023558350A patent/JP2024511611A/ja active Pending
- 2022-03-24 CA CA3212236A patent/CA3212236A1/en active Pending
- 2022-03-24 US US18/551,511 patent/US20240327382A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101985050B1 (ko) | 피라진카르복사미드 화합물 | |
| JP6318238B2 (ja) | スルファモイルピロールアミド誘導体およびｂ型肝炎を処置するための医薬品としてのその使用 | |
| RU2375352C2 (ru) | Амидные производные | |
| CN105555783B (zh) | 包含杂芳族环‑苄基‑酰胺‑环核心的自分泌运动因子抑制剂 | |
| JP2019523266A5 (https=) | ||
| IL295799A (en) | Trophomyosin receptor kinase (trk) degradation compounds and methods of use | |
| CN103476771B (zh) | 用于治疗自身免疫炎症的IL17和IFN-γ抑制 | |
| JP2019069941A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2023505258A5 (https=) | ||
| EP2590981B1 (en) | Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| JP2022534979A5 (https=) | ||
| JP2007519754A5 (https=) | ||
| EA031030B1 (ru) | Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение | |
| RU2008138993A (ru) | Производные хинолина | |
| WO2014181287A1 (en) | Heterocyclyl compounds and uses thereof | |
| KR20140048235A (ko) | 신규 트리플루오로메틸-옥사디아졸 유도체 및 질환의 치료에서의 그의 용도 | |
| JP2014505037A5 (https=) | ||
| JP2024511611A5 (https=) | ||
| RU2014142328A (ru) | Производные пиперидина в качестве агонистов gpr119 | |
| JP2023528073A (ja) | Ｇｐｒ６５モジュレーターとしてのｎ－フェニルアミノカルボニル、ピリジノ－、ピリミジノ及びベンゾトロパン | |
| CN111868040A (zh) | 2,4-二氨基喹唑啉衍生物及其医学用途 | |
| JP2019530708A5 (https=) | ||
| RU2020115915A (ru) | Бициклические сульфоны и сульфоксиды и способы их применения | |
| JP2015524825A5 (https=) |